MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CRNX has $1,196,031K in assets. $123,862K in debts. $110,901K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1512.07%
Cash Ratio
149.55%
Debt to Asset Ratio
10.36%
Assets Breakdown
    • Investment securities, amortized...
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Common stock and paid-in capital...
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
110,901 53,726
Restricted cash
500 500
Investment securities, amortized cost of 979,147 at september 30, 2025 and 1,088,561 at december 31, 2024
981,390 1,142,634
Prepaid expenses and other current assets
28,484 20,404
Total current assets
1,121,275 1,217,264
Property and equipment, net
14,377 14,670
Operating lease right-of-use assets
41,147 41,902
Restricted cash, net of current portion
800 800
Prepaid expenses and other assets, net of current portion
18,432 14,938
Total assets
1,196,031 1,289,574
Accounts payable and accrued expenses
33,674 38,086
Accrued compensation and related expenses
32,398 21,796
Deferred revenue
1,642 1,904
Operating lease liabilities
6,441 6,610
Total current liabilities
74,155 68,396
Operating lease liabilities, non-current
42,703 43,326
Deferred revenue, non-current
4,110 3,992
Other liabilities
2,894 2,334
Total liabilities
123,862 118,048
Common stock and paid-in capital, 0.001 par 200,000 shares authorized 94,548 shares issued and outstanding at september 30, 2025 92,926 shares issued and outstanding at december 31, 2024
2,364,699 2,334,538
Stock held in trust
-112
Accumulated other comprehensive income
2,194 1,621
Accumulated deficit
-1,294,612 -1,164,521
Stock held in trust
112 -
Total stockholders equity
1,072,169 1,171,526
Total liabilities and stockholders equity
1,196,031 1,289,574
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$28,484K Investment securities,amortized cost of 979,147...$981,390K Restricted cash$500K Cash and cashequivalents$110,901K Prepaid expenses andother assets, net of...$18,432K Restricted cash, net ofcurrent portion$800K Operating leaseright-of-use assets$41,147K Property and equipment,net$14,377K Total current assets$1,121,275K Total assets$1,196,031K Total liabilities andstockholders equity$1,196,031K Total stockholdersequity$1,072,169K Total liabilities$123,862K Stock held in trust$112K Accumulated deficit-$1,294,612K Accumulated othercomprehensive income$2,194K Common stock andpaid-in capital, 0.001...$2,364,699K Other liabilities$2,894K Deferred revenue,non-current$4,110K Operating leaseliabilities, non-current$42,703K Total currentliabilities$74,155K Operating leaseliabilities$6,441K Deferred revenue$1,642K Accrued compensationand related...$32,398K Accounts payable andaccrued expenses$33,674K

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. (CRNX)